ATTO Sale Disclosure
Walsh Colin · SEC Form 4 · Filed Aug 28, 2026
Sale
Calculated transaction value
$146.15K
Walsh Colin Director
ATTO
Transaction date
Aug 5, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 23 days later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,763 shares @ $21.61
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4/A
- Filing identifier
- 0001866174-26-000011
Filing cohort
Transactions in this filing
Showing 15 of 35
Trades
35
Issuers
1
Estimated value
$14.78M
Buys / sales
8 / 23
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 6, 2026 | $8.5M |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $2.2K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $15.45K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $74.91K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $4.41K |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 5, 2026 | $969.66K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $34.33K |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 5, 2026 | $121.89K |
| Attovia Therapeutics, Inc. ATTO Current | Sale | Aug 5, 2026 | $146.15K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $16.54K |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 5, 2026 | $609.37K |